General Information of the Protein
Protein ID
PT05357
Protein Name
Sodium/nucleoside cotransporter 2
Secondarily
Protein Name
Concentrative nucleoside transporter 2
Na(+)/nucleoside cotransporter 2
Sodium-coupled nucleoside transporter 2
Sodium/purine nucleoside co-transporter
Solute carrier family 28 member 2
Gene Name
SLC28A2
Secondarily
Gene Name
CNT2
Sequence
MEKASGRQSIALSTVETGTVNPGLELMEKEVEPEGSKRTDAQGHSLGDGLGPSTYQRRSRWPFSKARSFCKTHASLFKKILLGLLCLAYAAYLLAACILNFQRALALFVITCLVIFVLVHSFLKKLLGKKLTRCLKPFENSRLRLWTKWVFAGVSLVGLILWLALDTAQRPEQLIPFAGICMFILILFACSKHHSAVSWRTVFSGLGLQFVFGILVIRTDLGYTVFQWLGEQVQIFLNYTVAGSSFVFGDTLVKDVFAFQALPIIIFFGCVVSILYYLGLVQWVVQKVAWFLQITMGTTATETLAVAGNIFVGMTEAPLLIRPYLGDMTLSEIHAVMTGGFATISGTVLGAFIAFGVDASSLISASVMAAPCALASSKLAYPEVEESKFKSEEGVKLPRGKERNVLEAASNGAVDAIGLATNVAANLIAFLAVLAFINAALSWLGELVDIQGLTFQVICSYLLRPMVFMMGVEWTDCPMVAEMVGIKFFINEFVAYQQLSQYKNKRLSGMEEWIEGEKQWISVRAEIITTFSLCGFANLSSIGITLGGLTSIVPHRKSDLSKVVVRALFTGACVSLISACMAGILYVPRGAEADCVSFPNTSFTNRTYETYMCCRGLFQSTSLNGTNPPSFSGPWEDKEFSAMALTNCCGFYNNTVCA
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Transporter
>
Electrochemical transporter
>
SLC superfamily of solute carriers
>
SLC28 and SLC29 families of nucleoside transporters
>
SLC28 Na+-coupled nucleoside transport family
Function
Sodium-dependent and purine-selective transporter (PubMed:9435697, PubMed:10087507). Exhibits the transport characteristics of the nucleoside transport system cif or N1 subtype (N1/cif) (selective for purine nucleosides and uridine) (PubMed:9435697, PubMed:10087507, PubMed:21795683). Plays a critical role in specific uptake and salvage of purine nucleosides in kidney and other tissues (PubMed:9435697). May contribute to regulate the transport of organic compounds in testes across the blood-testis-barrier (Probable).
    Show/Hide
Uniprot ID
Primary ID:
O43868

Secondarily ID:
A8K7F9
O43239
Q52LZ0
    Show/Hide
Ensembl ID
ENSG00000137860
HGNC ID
HGNC:11002
Subcellular Location
Membrane
Apicolateral cell membrane
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000053 , COS-7
Compound ID Compound Name Compound Formula
CP0420092
(2R,3R,4S,5R)-2-[2-[[3-(4-hydroxybutoxy)-4-phenylphenyl]methylamino]benzimidazol-1-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C29H33N3O6
 1
1
IC50 = 62 nM
   TI
   LI
   LO
   TS
CP0420091
(2R,3R,4S,5R)-2-[6-amino-8-[(4-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C23H24N6O4
 1
1
IC50 = 640 nM
   TI
   LI
   LO
   TS
CP0464430
(2R,3R,4S,5R)-2-[6-amino-8-[[3-(4-hydroxybutoxy)-4-phenylphenyl]methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C27H32N6O6
 1
1
IC50 = 940 nM
   TI
   LI
   LO
   TS
CP0420026
(2R,3R,4S,5R)-2-[6-amino-8-[(4-pyridin-3-ylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C22H23N7O4
 1
1
IC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0402947
(2R,3R,4S,5R)-2-[6-amino-8-[(2-methoxy-4-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C24H26N6O5
 1
1
IC50 = 1100 nM
   TI
   LI
   LO
   TS
CP0420048
(2R,3R,4S,5R)-2-[6-amino-8-[[3-(3-hydroxypropoxy)-4-phenylphenyl]methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C26H30N6O6
 1
1
IC50 = 1100 nM
   TI
   LI
   LO
   TS
CP0445468
(2R,3R,4S,5R)-2-[6-amino-8-[(3-hydroxy-4-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C23H24N6O5
 1
1
IC50 = 1200 nM
   TI
   LI
   LO
   TS
CP0420046
(2R,3R,4S,5R)-2-[6-amino-8-[(2-hydroxy-4-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C23H24N6O5
 1
1
IC50 = 1300 nM
   TI
   LI
   LO
   TS
CP0420049
(2R,3R,4S,5R)-2-[6-amino-8-[(3-methoxy-4-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C24H26N6O5
 1
1
IC50 = 1300 nM
   TI
   LI
   LO
   TS
CP0493658
(2R,3R,4S,5R)-2-[6-amino-8-[(4-pyridin-2-ylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C22H23N7O4
 1
1
IC50 = 1500 nM
   TI
   LI
   LO
   TS
CP0420093
(2R,3R,4S,5R)-2-[6-amino-8-[[3-(5-hydroxypentoxy)-4-phenylphenyl]methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C28H34N6O6
 1
1
IC50 = 1600 nM
   TI
   LI
   LO
   TS
CP0420047
(2R,3R,4S,5R)-2-[6-amino-8-[(3-ethoxy-4-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C25H28N6O5
 1
1
IC50 = 2300 nM
   TI
   LI
   LO
   TS
CP0542133
(2R,3R,4S,5R)-2-[6-amino-8-[(4-pyridin-4-ylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C22H23N7O4
 1
1
IC50 = 2700 nM
   TI
   LI
   LO
   TS
CP0420153
(2R,3R,4S,5R)-2-[6-amino-8-[[3-(2-hydroxyethoxy)-4-phenylphenyl]methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C25H28N6O6
 1
1
IC50 = 3100 nM
   TI
   LI
   LO
   TS
CP0420090
methyl 2-[5-[[[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-8-yl]amino]methyl]-2-phenylphenoxy]acetate
   Show/Hide
C26H28N6O7
 1
1
IC50 = 3300 nM
   TI
   LI
   LO
   TS
CP0402946
(2R,3R,4S,5R)-2-[6-amino-8-[(4-phenyl-3-propoxyphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C26H30N6O5
 1
1
IC50 = 5200 nM
   TI
   LI
   LO
   TS
CP0453707
(2R,3R,4S,5R)-2-[6-amino-8-(naphthalen-2-ylmethylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C21H22N6O4
 1
1
IC50 = 5300 nM
   TI
   LI
   LO
   TS
CP0499769
(2R,3R,4S,5R)-2-[6-amino-8-[(3-chlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C17H19ClN6O4
 1
1
IC50 = 5400 nM
   TI
   LI
   LO
   TS
CP0464429
(2R,3R,4S,5R)-2-[6-amino-8-[(2-ethoxy-4-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C25H28N6O5
 1
1
IC50 = 5400 nM
   TI
   LI
   LO
   TS
CP0420088
2-[5-[[[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-8-yl]amino]methyl]-2-phenylphenoxy]acetamide
   Show/Hide
C25H27N7O6
 1
1
IC50 = 5500 nM
   TI
   LI
   LO
   TS
CP0507960
(2R,3R,4S,5R)-2-[6-amino-8-(naphthalen-1-ylmethylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C21H22N6O4
 1
1
IC50 = 5700 nM
   TI
   LI
   LO
   TS
CP0529621
(2R,3R,4S,5R)-2-[6-amino-8-[(2-chlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C17H19ClN6O4
 1
1
IC50 = 5700 nM
   TI
   LI
   LO
   TS
CP0572689
(2R,3R,4S,5R)-2-[6-amino-8-[(4-phenyl-2-propan-2-yloxyphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C26H30N6O5
 1
1
IC50 = 9300 nM
   TI
   LI
   LO
   TS
CP0420094
(2R,3R,4S,5R)-2-[6-amino-8-[(4-phenyl-3-propan-2-yloxyphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C26H30N6O5
 1
1
IC50 = 10400 nM
   TI
   LI
   LO
   TS
CP0174436
(2R,3R,4S,5R)-2-[6-amino-8-[(4-methylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C18H22N6O4
 1
1
IC50 = 11000 nM
   TI
   LI
   LO
   TS
CP0355938
(2R,3R,4S,5R)-2-[6-amino-8-[(4-chlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C17H19ClN6O4
 1
1
IC50 = 11000 nM
   TI
   LI
   LO
   TS
CP0530823
(2R,3R,4S,5R)-2-[6-amino-8-[(3-methoxyphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C18H22N6O5
 1
1
IC50 = 13000 nM
   TI
   LI
   LO
   TS
CP0499770
(2R,3R,4S,5R)-2-[6-amino-8-[(3-methylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C18H22N6O4
 1
1
IC50 = 19000 nM
   TI
   LI
   LO
   TS
CP0407561
9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-8-[[3-(4-hydroxybutoxy)-4-phenylphenyl]methylamino]-1H-purin-6-one
   Show/Hide
C27H31N5O7
 1
1
IC50 = 20100 nM
   TI
   LI
   LO
   TS
CP0441649
(2R,3R,4S,5R)-2-[6-amino-8-[(3-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C23H24N6O4
 1
1
IC50 = 21000 nM
   TI
   LI
   LO
   TS
CP0486894
(2R,3R,4S,5R)-2-[6-amino-8-[(4-methoxyphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C18H22N6O5
 1
1
IC50 = 36000 nM
   TI
   LI
   LO
   TS
CP0132050
adenosine-derived inhibitor, 6
   Show/Hide
C17H20N6O4
 1
1
IC50 = 52000 nM
   TI
   LI
   LO
   TS
CP0569331
(2R,3R,4S,5R)-2-[6-amino-8-[(2-methylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C18H22N6O4
 1
1
IC50 = 65000 nM
   TI
   LI
   LO
   TS
CP0390514
[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl N-pentylcarbamate
   Show/Hide
C16H24N6O5
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0390515
[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl ethyl carbonate
   Show/Hide
C13H17N5O6
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0390516
[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl hexanoate
   Show/Hide
C16H23N5O5
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0390517
[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl acetate
   Show/Hide
C12H15N5O5
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0390518
(2R,3R,4S,5R)-2-[6-amino-8-[(2-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C23H24N6O4
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0390519
(2R,3R,4S,5R)-2-[6-amino-8-[(2-methoxyphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
   Show/Hide
C18H22N6O5
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0398080
[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl N-benzylcarbamate
   Show/Hide
C18H20N6O5
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0398081
[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl pentyl carbonate
   Show/Hide
C16H23N5O6
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0398082
Ado-5&#39;-ethylcarboxylate
   Show/Hide
C13H17N5O5
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0453705
[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl N-methylcarbamate
   Show/Hide
C12H16N6O5
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0453706
[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl 2-phenylacetate
   Show/Hide
C18H19N5O5
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0486893
[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl methyl carbonate
   Show/Hide
C12H15N5O6
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0569330
[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl benzyl carbonate
   Show/Hide
C18H19N5O6
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0858176
5'-O-(Ethylcarbamoyl)adenosine
   Show/Hide
C13H18N6O5
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0050531
1-(2,4-dihydroxy-6-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-3-(4-hydroxyphenyl)propan-1-one
   Show/Hide
C21H24O10
 1
1 IC50 = 100000 nM
Clinical Information about the Protein
Target 1 ( Solute carrier family 28 member 2 (SLC28A2) )
Target Type Literature-reported Target
Similar Protein(s) and Bioactivity Statistics
50% Identity
Protein ID Protein Name Protein Organism
PT06620 Sodium/nucleoside cotransporter 2 Rattus norvegicus, Rat